Inhibition of PRMT5 sensitizes B-cell non-Hodgkin lymphoma cells to both intrinsic and extrinsic apoptotic cell death
RNA-seq (gene expression) · human · 12 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 12 samples: 3 × OCI_Ly1_c vs 3 × OCI_Ly1_J vs 3 × SUDHL4_c vs 3 × SUDHL4_JGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Inhibition of PRMT5 sensitizes B-cell non-Hodgkin lymphoma cells to both intrinsic and extrinsic apoptotic cell deathBlood neoplasia · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE311739_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1370848 and SRA study SRP649700. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 12 samples.
How we read this: 4 replicated groups read from 12 sample titles; they account for 12 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9330657 OCI_Ly1_c1 OCI_Ly1_c
- GSM9330658 OCI_Ly1_c2 OCI_Ly1_c
- GSM9330659 OCI_Ly1_c3 OCI_Ly1_c
- GSM9330660 OCI_Ly1_J1 OCI_Ly1_J
- GSM9330661 OCI_Ly1_J2 OCI_Ly1_J
- GSM9330662 OCI_Ly1_J3 OCI_Ly1_J
- GSM9330663 SUDHL4_c1 SUDHL4_c
- GSM9330664 SUDHL4_c2 SUDHL4_c
- GSM9330665 SUDHL4_c3 SUDHL4_c
- GSM9330666 SUDHL4_J1 SUDHL4_J
- GSM9330667 SUDHL4_J2 SUDHL4_J
- GSM9330668 SUDHL4_J3 SUDHL4_J
- GSE185651 Triptolide sensitizes cancer cells to nucleoside DNA methyltransferase inhibitors through inhibition of DCTPP1 mediated cell-intrinsic resistance 28 samples shares inhibition, sensitizes, intrinsic
- GSE261512 PRMT5 promotes growth of pediatric high grade glioma [bulk RNA-seq] 20 samples shares prmt5
- GSE275215 Productive mRNA chromatin escape is promoted by PRMT5 activity - Cytoplasm Nucleoplasm Chromatin Fractions 18 samples shares prmt5
- GSE261514 PRMT5 promotes growth of pediatric high grade glioma. 50 samples shares prmt5
- GSE254732 Inhibition of PCSK9 with evolocumab modulates lipoproteins and monocyte activation in high-risk ASCVD subjects 215 samples shares inhibition
- GSE275078 In vitro drug screening of RAF/MEK/ERK Inhibitors in combination with Autophagy inhibition in the context of two PDA Cell Lines 136 samples shares inhibition
- GSE266219 Clinical and Immunological Responses to Combined JAK Inhibition and PD-1 immunotherapy for Lung Cancer Patients 79 samples shares inhibition
- GSE338135 NRAS knockdown reverses monocytic cell state and resensitizes resistant FLT3-AML cells to gilteritinib 75 samples shares sensitizes
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.